2018 and HIV Prevention: AVAC's Take

January 10, 2018

In this episode hear about recently published findings from a study out of Rakai, Uganda confirm that scaling up of a combination of existing interventions, such as voluntary medical male circumcision and antiretroviral therapy provides protection from HIV at the population-level. How do we apply these findings at the global level? How should advocates prepare for results—anticipated in 2019—of the ECHO trial that’s looking at the effect of hormonal contraceptives on HIV risk? And what needs to happen in 2018 to reach long-term global targets for ending the epidemic?

Building on our advocacy agenda laid out in the December episode, this episode of Px Pulse expands on the challenges and possibilities for 2018!

Listen to the full podcast here. (8:04)

Highlights

• Seven Large Scale Trials in 2018: What AVAC’s watching For (1:58)
• Preparing for the Echo Results, Due in 2019 (1:32)
• The Dapivirine Ring: Rolling it out right, if approved (2:18)
• Combination Prevention in Rakai Uganda: How to apply recent findings (1:42)

Additional Resources

• 2017: HIV Prevention Pipeline
• ECHO Trial Details from AVAC’s Resource Database
• Link to the ECHO Consortium
• Webinar: An Update on Hormonal Contraception and HIV
• AVAC’s Focus Page on Combination Prevention
• National Institue of Health’s Press Release on Rakai Findings in 2017

More Px Pulse

For more episodes of Px Pulse, click here.